Photochemistry of cis,trans-[Pt(en)(I)2(OH)2] complex in aqueous solutions

Primary processes in photophysics and photochemistry of a potential light-activated anti-cancer dirhodium complex

Photophysics and photochemistry of a potential light-activated cytotoxic dirhodium complex [Rh2(µ-O2CCH3)2(bpy)(dppz)](O2CCH3)2, where bpy = 2,2'-bipyridine, dppz = dipyrido[3,2-a:2',3'-c]phenazine (Complex 1 or Rh2) in aqueous solutions was studied by means of stationary photolysis and time-resolved methods in time range from hundreds of femtoseconds to microseconds. According to the literature, Complex 1 demonstrates both oxygen-dependent (due to singlet oxygen formation) and oxygen-independent cytotoxicity. Photoexchange of an acetate ligand to a water molecule was the only observed photochemical reaction, which rate was increased by oxygen removal from solutions. Photoexcitation of Complex 1 results in the formation of the lowest triplet electronic excited state, which lifetime is less than 10 ns. This time is too short for diffusion-controlled quenching of the triplet state by dissolved oxygen resulting in 1O2 formation. We proposed that singlet oxygen is produced by photoexcitation of weakly bound van der Waals complexes [Rh2…O2], which are formed in solutions. If this is true, no oxygen-independent light-induced cytotoxicity of Complex 1 exists. Residual cytotoxicity deaerated solutions are caused by the remaining [Rh2…O2] complexes.

Platinum(IV) Complexes of the 1,3,5-Triamino Analogue of the Biomolecule Cis-Inositol Designed as Innovative Antineoplastic Drug Candidates

Metal complexes occupy a special place in the field of treatment and diagnostics. Their main advantages stem from the possibility of fine-tuning their thermodynamic properties and kinetic behavior in the biological milieu by applying different approaches such as properly constructed inner coordination sphere, appropriate choice of ligands, metal oxidation state, redox potential, etc., which are specific to these compounds. Here we discuss the design and synthesis of two octahedral cationic Pt(IV) complexes of the tridentate ligand all-cis-2,4,6-triaminocyclohexane-1,3,5-triol (taci) with composition, fac-[Pt(taci)I₃]⁺, 1 and bis-[Pt(taci)₂]⁴⁺, 2 as well as the potential for their application as antineoplastic agents. The complexes have been isolated in a solid state as: fac-[Pt(taci)I₃]I·3H₂O (1A), fac-[Pt(taci)I₃]I (1B), fac-[Pt(taci)I₃]I·2DMF (1C), bis-[Pt(taci)₂](CO₃)₂·6H₂O (2A) by changing the acidity of the reaction systems, the molar ratios of the reagents and the counterions, and by re-crystallization. The ligand taci is coordinated through the NH₂-groups, each molecule occupying three coordination places in the inner coordination sphere of Pt(IV). Monitoring of the hydrolysis processes of 1A and 2A at different acidity showed that while 2A remained stable over the study period, the I⁻-ions in 1A were successively substituted, with the main product under physiologically mimetic conditions being fac,cis-[Pt(taci)I(OH)₂]⁺ (h2). The antiproliferative tests involved eight cancer cell models, among which chemosensitive (derived from leukemias and solid tumors) and chemoresistant human Acute myeloid leukemia lines (HL-60/Dox, HL-60/CDDP), as well as the non-malignant kidney’ cells HEK-293T showed that the complexes 1A and 2A are characterized by a fundamentally different profile of chemosensitivity and spectrum of cytotoxic activity compared to cisplatin. The new Pt(IV) complexes were shown to be more effective in selectively inhibiting the proliferation of human malignant cells compared to cisplatin. Remarkable activity was recorded for 1A, which showed an effect (IC₅₀ = 8.9 ± 2.4) at more than 16-fold lower concentration than cisplatin (IC₅₀ = 144.4 ± 9.8) against the resistant cell line HL-60/CDDP. In parallel, 1A exhibited virtually the same cytotoxic effect against the parental HL-60 cells (IC₅₀ = 9.0 ± 1.2), where cisplatin displays comparable chemosensitivity (IC₅₀ = 8.3 ± 0.8). The determined resistance indices (RI~1) show unequivocally that the resistant lines are sensitive to both compounds tested; therefore, they are capable of overcoming the mechanisms of cisplatin resistance. The structural features of these compounds and their promising pharmacological properties justify their inclusion in the group of “non-classical metal-based antitumor compounds” and are a prerequisite for the admission of alternative mechanisms of action.

Photoinduced Deposition of Platinum from (Bu4N)2[Pt(NO3)6] for a Low Pt-Loading Pt/TiO2 Hydrogen Photogeneration Catalyst

An efficient method for the deposition of ionic platinum species PtO_x onto a TiO₂ surface was developed on the basis of light-induced activation of the [Pt(NO₃)₆]^2- anion. The deposited PtO_x species with an effective Pt oxidation state between +4 and +2 have an oxygen-made environment and include single ion centers {PtO_n} and polyatomic ensembles {Pt_nO_m} connected to a TiO₂ surface with Pt-O-Ti bonds. The resulting PtO_x/TiO₂ materials were tested as photocatalysts for the hydrogen evolution reaction (HER) from a water ethanol mixture and have shown uniquely high activity with the rate of H₂ evolution achieving 11 mol h^-1 per gram of Pt, which is the highest result for such materials reported to date. A combination of spectral methods shows that, under HER conditions, reduction of the supported PtO_x species leads to the formation of well-dispersed nanoparticles of metallic platinum attached on the surface of TiO₂ by Ti-O-Pt bonds. The high activity of the PtO_x/TiO₂ materials is believed to result from a combination of uniform distribution of small platinum nanoparticles over the titania surface and their close interaction with TiO₂.

Mechanistic study of the trans,cis,cis-[RuCl2(DMSO)2(H2O)2] complex photochemistry in aqueous solutions

It is known that trans,cis,cis-[RuCl2(DMSO)2(H2O)2] (1a) complexes, which are formed upon dissolution of trans-[RuCl2(DMSO)4] in water, demonstrate light-induced cytotoxicity. The mechanistic study of 1a photochemistry has been performed using ultrafast pump-probe spectroscopy, laser flash photolysis and stationary photolysis. The first stage of 1a photochemistry is the photoexchange of a DMSO ligand to a water molecule; its quantum yield is wavelength-dependent (estimating by values 0.3 and 0.04 upon irradiation at 308 and 430 nm, respectively). The mechanism of photoexchange is complicated involving at least four Ru(ii) intermediates. Two tentative mechanisms of the process are proposed.

A cis,fac-[RuCl2(DMSO)3(H2O)] complex exhibits ultrafast photochemical aquation/rearrangement

It is known that both cis,fac-[RuCl2(DMSO)3(H2O)] (1a) and trans,cis,cis-[RuCl2(DMSO)2(H2O)2] (2a) complexes, which are formed on the dissolution of trans and cis-isomers of [RuCl2(DMSO)4] in water, demonstrate light-induced anticancer activity. The first stage of 1a photochemistry is its transformation to 2a occurring with a rather high quantum yield, 0.64 ± 0.17. The mechanism of the 1a → 2a phototransformation was studied by means of nanosecond laser flash photolysis and ultrafast pump-probe spectroscopy. The reaction occurs in the picosecond time range via the formation and decay of two successive intermediates interpreted as Ru(ii) complexes with different sets of ligands. A tentative mechanism of phototransformation is proposed.